Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIAF
DateTimeSourceHeadlineSymbolCompany
12/06/202413:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202414:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
02/05/202413:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
24/04/202413:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
09/04/202413:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
01/04/202414:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202418:15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202417:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202417:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
08/03/202402:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
06/03/202415:45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202414:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202422:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202413:00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
21/02/202413:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
06/02/202413:00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
31/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
30/01/202413:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202401:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202401:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202401:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
23/01/202413:00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
08/01/202413:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
08/12/202321:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
05/12/202313:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF